Skip to content
10-K

Annual Report

BioNeutral Group, Inc

0001213900-14-000843

← back to feed
Filed
Feb 13, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Feb 4, 2014 798.18M sh
Operating Cash Flow FY 2013 · Oct 31, 2013 −$711.47K
Operating Cash Flow FY 2013 · Oct 31, 2012 −$1.36M
Cash And Equivalents FY 2013 · Oct 31, 2013 $702
Cash And Equivalents FY 2013 · Oct 31, 2012 $676
Cash And Equivalents FY 2013 · Oct 31, 2011 $3.22K
Stockholders Equity FY 2013 · Oct 31, 2013 $5.38M
Stockholders Equity FY 2013 · Oct 31, 2012 $7.45M
Current Liabilities FY 2013 · Oct 31, 2013 $2.6M
Current Liabilities FY 2013 · Oct 31, 2012 $1.63M
Total Liabilities FY 2013 · Oct 31, 2013 $4.06M
Total Liabilities FY 2013 · Oct 31, 2012 $2.42M
Current Assets FY 2013 · Oct 31, 2013 $25.11K
Current Assets FY 2013 · Oct 31, 2012 $4.68K
Total Assets FY 2013 · Oct 31, 2013 $9.28M
Total Assets FY 2013 · Oct 31, 2012 $9.98M
Rd Expense FY 2013 · Oct 31, 2013 $213.42K
Rd Expense FY 2013 · Oct 31, 2012 $237.03K
Net Income FY 2013 · Oct 31, 2013 −$2.92M
Net Income FY 2013 · Oct 31, 2012 −$2.39M
Operating Income FY 2013 · Oct 31, 2013 −$3.07M
Operating Income FY 2013 · Oct 31, 2012 −$2.54M
Gross Profit FY 2013 · Oct 31, 2013 $6.6K
Gross Profit FY 2013 · Oct 31, 2012 $2.15K
Cost Of Revenue FY 2013 · Oct 31, 2013 $14.69K
Cost Of Revenue FY 2013 · Oct 31, 2012 $2.44K
Revenue FY 2013 · Oct 31, 2013 $21.29K
Revenue FY 2013 · Oct 31, 2012 $4.59K